Extractive spectrophotometric methods for the novel antidepressant drug in bulk and pharmaceutical dosage forms by using bromthymol blue and bromcresol green

Analytical Letters

Volumn 36, Issue 6, 2003, Pages 1183-1196

  Erk, Nevin ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Bromcresol green; Bromthymol blue; First derivative spectrophotometry; Ion association complexes; Reboxetine

Indexed keywords

ANTIDEPRESSANT AGENT; BROMOCRESOL GREEN; BROMOTHYMOL BLUE; REBOXETINE;

ARTICLE; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG ISOLATION; SPECTROPHOTOMETRY; TABLET;

MYCOBACTERIUM BOVIS BCG;

EID: 0038218404     PISSN: 00032719     EISSN: None     Source Type: Journal    
DOI: 10.1081/AL-120020152     Document Type: Article

References (21)

1. Benedetto, F.; Giacomo, D.M.; Gioacchino, M.; Salvatore, M.; Sergio, D.R.; Massimo, D.G. The effects of reboxetine on human sleep architecture in depression: preliminary results. J. Affect Disorders 2002, 71, 273.
2. Kent, J.M.; SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet 2000, 355, 911.
3. Brunello, N.; Mendlewicz,J.; Kasper, S.; Leonard, B.; Montgomery, S.; Craig Nelson, J.; Paykel, E.; Versiani, M.; Racagni, G. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur. Neuropsychopharmacology 2002, 12, 461.
4. Dostert, P.; Benedetti, M.; Poggesi, I. Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor. Eur. Neuropsychopharm. 1997, 7, 23.
5. Katona, C.; Bercoff, E.; Chiu, E.; Tack, P.; Yersiani, M.; Woelk, H. Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised tria. J. Affect Disorders 1999, 55, 203.
6. Montgomery, S.A. Is there a role for a pure noradrenergic drug in the treatment of depression? Eur. Neuropsychopharm. 1997, 7, S3.
7. Frigerio, E.; Pianezzola, E.; Benedetti, M.S. Sensitive procedure for the determination of reboxetine enantiomers in human plasma by reversed-phase high-performance liquid chromatography with fluorimetric detection after chiral derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate. J. Chromatogr. A 1994, 660, 351.
8. Walters, R.R.; Buist, S.C. Improved enantioselective method for the determination of the enantiomers of reboxetine in plasma by solid-phase extraction, chiral derivatization, and column-switching high-performance liquid chromatography with fluorescence detection. J. Chromatogr. A 1998, 828, 167.
9. Hartter, S.; Weigmann, H.; Hiemke, C. Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection. J. Chromatogr. B 2000, 740, 135.
10. Ohman, D.; Norlander, B.; Peterson, C.; Bengtssont, F. Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC. Ther. Drug Monit. 2001, 23, 27.
11. Edwards, D.M.; Pellizzoni, C.; Breuel, H.P.; Berardi, A.; Castelli, M.G.; Frigerio, E.I.; Poggesi, I.; Rocchetti, M.; Dubini, A.; Benedetti, M.S. Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding. Biopharm. Drug Dispos. 1995, 16, 443.
12. Ohman, D.; Norlander, B.; Peterson, C.; Bengtssont, F. Simultaneous determination of reboxetine and O-desethylreboxetine enantiomers using enantioselective reversed-phase high performance liquid chromatography. J. Chromatogr. A 2002, 947, 247.
13. Raggi, M.A.; Mandrioli, R.; Casamenti, G.; Volterra, V.; Pinzauti, S. Determination of reboxetine, a recent antidepressant drug, in human plasma by means of two high-performance liquid chromatography methods. J. Chromatogr. A 2002, 949, 23.
14. Raggi, M.A.; Bugamelli, F.; Sabbioni, C.; Ferranti, F.; Fanali, S.; Volterra, V. Analysis of reboxetine, a novel antidepressant drug, in pharmaceutical tablets by capillary electrophoresis and derivative spectrophotometry. J. Pharm. Biomed. Anal. 2002, 27, 209.
15. Rahman, N.; Hejaz-Azmi, S.N. Extractive spectrophotometric methods for determination of diltiazem HCl pharmaceutical formulations using bromthymol blue, bromophenol blue, bromocresol green. J. Pharm. Biomed. Anal. 2000, 24, 33.
16. Özkul, A.; Öztunç, A. Determination of maprotiline hydrochloride in tablets by ion-pair extraction using bromthymol blue. Pharmazie 2000, 55, 321.
17. Ramesh, K.C.; Gowda, B.G.; Melwanki, M.B.; Seetharamappa, J.; Keshavayya, J. Extractive spectrophotometric determination of antiallergic drugs in pharmaceutical formulations using bromopyrogallol red and bromthymol blue. Anal. Sci. 2001, 17, 1101.
18. Marona, H.R.; Schapoval, E.E. Spectrophotometric determination of sparfloxacin in pharmaceutical formulations using bromthymol blue. J. Pharm. Biomed. Anal. 2001, 26, 501.
19. Perez-Ruiz, T.; Martinez-Lozano, C.; Tomas, V.; Sanz, A.; Sahuquillo, E.; Flow-injection extraction-spectrophotometric method for the determination of ranitidine in pharmaceutical preparations. J. Pharm. Biomed. Anal. 2001, 26, 609.
20. Issa, Y.M. Abdel-Gawad, F.M.; Abou Table, M.A.; Hussein, H.M. Spectrophotometric determination of ofloxacin and lomefloxacin hydrochloride with some sulphonphthalein dyes. Anal. Lett. 1997, 30, 2071.
21. El-Ansary, A.L.; Issa, Y.M.; Selim, W. Spectrophotometric determination of trimethoprim in pure form and in pharmaceutical preparations using bromthymol blue, bromocresol green and alizarin red S. Anal. Lett. 1999, 32, 955.